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Abstract Three-dimensional (3D) printing, also referred
to as additive manufacturing, is a technology that allows
for customized fabrication through computer-aided design.
3D printing has many advantages in the fabrication of
tissue engineering scaffolds, including fast fabrication,
high precision, and customized production. Suitable scaf-
folds can be designed and custom-made based on medical
images such as those obtained from computed tomography.
Many 3D printing methods have been employed for tissue
engineering. There are advantages and limitations for each
method. Future areas of interest and progress are the
development of new 3D printing platforms, scaffold design
software, and materials for tissue engineering applications.
Keywords Additive manufacturing (AM) 
Tissue engineering  Scaffold
1 Introduction
Three-dimensional (3D) printing is a commonly used term
that is often considered synonymous with additive manu-
facturing. 3D printing has drawn a lot of public attention,
especially for its use in medical research. Additive manu-
facturing refers to a group of techniques that can generate a
model with reduced waste and higher energy efficiency
compared to those of conventional fabrication methods.
The ability to create a 3D structure in a green and sus-
tainable way through the use of 3D printing has taken
fabrication techniques to a new level.
Currently, 3D printing technology can be used for tissue
regeneration purposes. In the past two decades, increasing
attention has been given to tissue engineering. With tissue
and organ regeneration, the hurdles of traditional thera-
peutic methods may be overcome by autologous trans-
plantation. As these technologies gain acceptance, the
shortage of donor organs or chronic rejection of transplants
may no longer be a problem.
The goal of tissue engineering is to create tissue or
organ replacement strategies. Scaffolds play an important
role in tissue engineering. They serve as templates for cell
adhesion and the recruitment of cells to infiltrate deep into
a defect site. Moreover, scaffolds can provide mechanical
supports during tissue regeneration. With biomimetic
scaffolds, researchers attempt to create an environment
close to the natural extracellular matrix (ECM) of that
organ, in which cells could be guided to create a new tissue
with appropriate function.
Conventional scaffold fabrication methods include sol-
vent casting and particulate leaching [1, 2], fiber spinning
[3], emulsion freeze drying [4], and phase separation [5].
Polymer-based scaffolds can then be acquired. These
methods have been studied extensively [6–9]. Various
polymers have been crafted into scaffolds using these
methods and tested. Although conventional scaffold fab-
rication techniques have been improved, the physical
properties of scaffolds fabricated by these methods still
have limitations (i.e., controlling scaffold pore size,
geometry, and porosity). Moreover, it is difficult to control
the shape and dimension of scaffolds using these methods.
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Unlike conventional scaffold fabrication techniques,
which are highly process-dependent, additive manufactur-
ing is design-dependent for scaffold fabrication. The size,
geometry, and porosity can be precisely controlled during
additive manufacturing to a patient’s specification. In
addition, scaffolds made using additive manufacturing
techniques are highly reproducible. More importantly, a
custom-made scaffold with specified dimensions and
geometry can be prepared. When applying a reasonable
design, the cell–cell interaction and cell–ECM interaction
can be manipulated. Scaffold design can be performed
easily with computer-aided design [10]. By adjusting the
parameters of manufacturing, tissue engineering scaffolds
can be made to fit different purposes.
2 Fused Deposition Modeling
Various additive manufacturing techniques have been
applied in tissue engineering. They can be categorized into
two large groups according to the power source used dur-
ing fabrication, namely heat or light. Fused deposition
modeling (FDM) is a typical heat-using technique for 3D
scaffold fabrication. A scheme of FDM is shown in Fig. 1.
In this method, the filament of the desired material is fed
and melted in a liquefier by heat before extrusion from the
nozzle. The melted polymer is extruded from the nozzle
and deposited layer by layer to create a scaffold. The
process temperature depends on the melting temperature of
building materials and is generally too high for cells to
survive or for bioactive molecules to retain their activity.
Zein et al. [11] fabricated a honeycomb-structured poly-
caprolactone (PCL) scaffold that has a channel size of
160–700 lm, a filament diameter of 260–370 lm, and a
porosity of 48–77 %. The working temperature was
determined as 125 ± 5 C, which is considered a relatively
narrow process window for polymer processing. Hsu et al.
used poly(D,L-lactide) (PLA) as the feed material. Scaffolds
with various fiber stacking orientations were produced and
examined [12]. They also fabricated scaffolds with con-
centric cylinder geometry (with interconnected hollows)
and tested them. Furthermore, collagen was placed in a
poly(D,L-lactide-co-glycolide) (PLGA) scaffold to promote
chondrocyte growth [13].
3 Liquid Frozen Deposition Manufacturing
There are some drawbacks to FDM. During the process, the
use of heat as the power source to melt the material can
have undesired effects. The operating temperature of the
system is too high for cells and other biomolecules. With
this limitation, cells are hardly printed together with the
material to form a cell-containing scaffold, and it is also
difficult to incorporate biomolecules such as growth factors
into the scaffold. To overcome the limitations associated
with FDM, a lower-temperature cooling platform, called
liquid frozen deposition manufacturing (LFDM), was
developed. A scheme of LFDM is shown in Fig. 2. A low-
temperature platform/chamber is required for the process.
LFDM involves low temperature during processing.
Natural (e.g., chitosan) scaffolds as well as synthetic (e.g.
PLGA) scaffolds were made with LFDM from polymer
solutions by Hsu et al. for various applications [14–16].
Chitosan dissolved in acetic acid was printed and freeze-
dried [14]. PLGA scaffolds were fabricated from a PLGA
solution in an organic solvent (1,4-dioxane) using LFDM.
The surface pore size of each of the stacking fibers was
controlled by adjusting the concentration of the PLGA
solution in the organic solvent. The pore size decreased
from 2–3 lm to \1 lm as the concentration of PLGA
solution was increased from 15 to 25 %. These scaffolds
Fig. 1 Scheme of fused
deposition manufacturing
(FDM). Melted polymer is
extruded from nozzle to build
scaffold
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were found to promote the secretion of ECM from chon-
drocytes, which formed natural lacunae [15]. PLGA scaf-
folds were combined with alginate gel for the
chondrogenesis of mesenchymal stem cells (MSCs) [16].
More recently, Hung et al. [17] developed a water-based
system for printing polyurethane scaffolds. In their study,
the organic solvent was replaced by water. Moreover,
Xiong et al. [18] manufactured poly(L-lactic acid) (PLLA)/
(tricalcium phosphate) composite scaffolds for bone tissue
engineering. LFDM is considered as a more efficient pro-
cedure since it does not require heating. However, because
LFDM normally requires freeze-drying after fabrication, it
did not allow cells to be printed with the materials during
the process. Although cells cannot be directly printed, it is
expected that bioactive compounds or biomolecules could
be incorporated with the scaffold during the process [19].
4 Stereolithography
Stereolithography (SLA) employs a single beam laser to
polymerize or crosslink a photopolymer resin. A scheme of
SLA is shown in Fig. 3. By drawing on the liquid
photopolymer resin with a light beam, thin layers of
polymer are stacked layer by layer. A mixture of diethyl
fumarate (DEF)/poly(propylene fumarate) (PFF) was used
by Cooke et al. [20] to fabricate a scaffold. An 80-layer
scaffold with a 4-mm thickness was fabricated using SLA.
Holes and slots of various sizes were made on the scaffold.
Protrusions were also made on the scaffold, which
demonstrated the ability of SLA to build scaffolds various
geometries. Melchels et al. [21] prepared a mathematically
defined scaffold. The porous scaffold was built with two
kinds of resin, either a PLA-based resin or a poly(D,L-lac-
tide-co-e-caprolactone)-based resin. By changing the pore
size, resin selection, and pore architecture, the mechanical
properties of the scaffold may be manipulated. Flexible and
elastic materials could also be crafted into scaffolds via
SLA. Schu¨ller-Ravoo et al. used poly(trimethylene car-
bonate)-based resin to build scaffolds for cartilage tissue
engineering [22]. When the scaffolds were seeded with
bovine chondrocytes, glycosaminoglycans and fibrillar
collagens were deposited after 6 weeks of culture. The
resulting scaffolds presented a 50 % increase in compres-
sive modulus.
In addition to stiff resin, hydrogels may be rendered as
scaffolds through SLA processes [23–25]. While using
hydrogel as the building material, the temperature is gen-
erally low enough for cells to survive. This makes it pos-
sible to encapsulate cells during scaffold fabrication.
Dhariwala et al. [23] used a photopolymerizable hydrogel
as the building material. Poly(ethylene oxide) (PEO) and
poly(ethylene glycol) dimethacrylate were mixed and used
as the building materials in the study. The resulting
hydrogels did not have a high elastic modulus; however,
the mechanical properties were comparable to those of
other soft tissues (e.g., breast tissue). Furthermore, Chinese
hamster ovary cells were successfully encapsulated in these
hydrogel scaffolds. This result suggests that hydrogels may
be used to encapsulate cells while maintaining cell via-
bility. A PEO/poly(ethylene glycol) diacrylate (PEGDA)
hydrogel was used to build scaffolds by Chan et al. [24].
Fig. 2 Scheme of liquid-frozen
deposition manufacturing
(LFDM). Low-temperature
working chamber/platform is
required in process
Fig. 3 Scheme of stereolithography (SLA). Single laser beam scans
surface of resin to polymerize or crosslink polymer resin
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The elastic moduli varied from 4.73 ± 0.46 to
503 ± 57 kPa, depending on the molecular weight of the
PEGDA used in the hydrogels. With a wider range of
elastic moduli, the hydrogels have more possibilities for
various applications. NIH/3T3 cells have been encapsu-
lated in hydrogel, retaining long-term viability. This was an
important step for SLA in cell encapsulation. Seck et al.
[25] produced a hydrogel structure with SLA using
poly(ethylene glycol)/PDLA-based resins. Both porous and
non-porous structures were prepared. The pore size of the
porous structure ranged from 387 to 558 lm with an
average size of 423 lm. Based on micro-computed
tomography (lCT) data, a porosity of 52 % was deter-
mined, while the porosity of the designed architecture was
55 %. SLA processes have been used to render the internal
and external morphology of scaffolds with high accuracy,
and have the ability to build structures as designed. For a
patient-specific tissue, Du et al. [26] constructed a viable
artificial bone substitute with SLA through a series of
manufacturing processes. With the use of lCT images, the
constructs had the correct external shape and optimized
internal channels.
5 Digital Light Processing
Digital light processing (DLP) 3D printing uses a laser to
cure a polymer. A scheme of DLP is shown in Fig. 4.
Compared to SLA, which is a bottom-up process, DLP is a
top-down process and is relatively faster. During the pro-
cess, a digital mirror device (DMD) is used to control the
curing laser beam. DMD has an array of micro-mirrors,
which can rotate independently to control the laser beam to
an on or off state. With the use of DMD, an entire layer can
be cured at once, which makes DLP faster than the
conventional SLA process. For tissue engineering, PEGDA
hydrogel scaffolds were fabricated by Lu et al. [27] via
DLP. In their study, murine-bone-marrow-derived cells
were successfully encapsulated in the construct. A complex
porous scaffold was fabricated by Gauvin et al. [28]. The
hydrogel scaffold uses gelatin methacrylate (GelMA) as
the building material. By varying the structure and the
prepolymer concentration, the mechanical properties of
scaffolds can be tuned. Furthermore, the interconnected
pores allow for uniform distribution of human umbilical
vein endothelial cells (HUVECs). As a result, scaffolds
with high cell density and homogeneous cell distribution
can be generated at the end of the culture period.
6 Selective Laser Sintering
Selective laser sintering (SLS) is another technique com-
monly used in scaffold fabrication (as shown in Fig. 5). It
uses a high-power laser for polymer powder sintering to
form a scaffold. During sintering, a high-power laser, for
example a carbon dioxide laser, is used to draw on the
powders. The polymer powder can be fused into large parts,
and thus the scaffold is made layer by layer. This technique
is preferred for rendering complex porous scaffolds. Unlike
FDM and SLA, SLS does not require supports. The unsin-
tered powder provides support for the model during the
build process. For bone tissue engineering, Williams et al.
[29] manufactured porous PCL scaffolds via SLS. The
mechanical properties of the resulting scaffolds are within
the lower range of those of human trabecular bone. The
porous structure provides spaces for tissue ingrowth as well
as sufficient mechanical strength. PCL/hydroxyapatite, a
biocomposite, was used to fabricate tissue engineering
scaffolds by Wiria et al. [30]. A porous polyvinyl alcohol
Fig. 4 Scheme of digital light
processing (DLP). Digital
mirror device is used in process
to illuminate entire layer of
resin surface
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(PVA) scaffold was fabricated for bone tissue engineering
by Shuai et al. via SLS [31]. The porous structure of the
scaffold was controllable and totally interconnected. The
porosity of the scaffolds was measured to be 67.9 ± 2.7 %.
A porous scaffold proposed by Yeong et al. [32] was fab-
ricated for cardiac tissue engineering. In this study, SLS was
used to fabricate PCL scaffolds. Both PLA and PCL scaf-
folds fabricated by SLS have demonstrated feasibility for
specific tissue engineering applications. Chen et al. ren-
dered PCL scaffolds for use in cartilage tissue engineering
research [33]. Chondrocytes were seeded in collagen and
further loaded into the scaffold. Studies on pore geometry
and distribution were performed. Results showed that a
customized and designed scaffold could be made with the
combination of these technologies for cartilage tissue
engineering. Regarding the starting materials for the SLS
process, Ca-P/poly(hydroxybutyrate-co-hydroxyvalerate)
nanocomposite material was used by Duan and Wang to
fabricate microspheres [34]. Normally, bioactive molecules
are not able to retain their activity after the SLS process.
These microspheres could encapsulate proteins and are
suitable for SLS processes to build up scaffolds for tissue
regeneration. Although the encapsulation efficiency was
only 24.51 ± 0.60 %, this study demonstrated the potential
of biomolecule incorporation within the materials used for
SLS scaffold fabrication. A summary of the advantages and
disadvantages of various 3D printing techniques is shown in
Table 1.
7 Other Techniques
There are still many techniques in the field of additive
manufacturing that remain to be explored for their use in
tissue engineering. Compared to the techniques introduced
above, some methods have higher resolution, allowing
smaller line widths of the fabricated scaffold. Some pro-
cesses are suitable for ‘‘printing’’ a scaffold and cells at the
same time or for printing cells directly as materials, which
are fused layer upon layer during scaffold rendering. With
these kinds of techniques, cell-containing scaffolds can be
fabricated. Kolesky et al. [35] printed perfusable channels,
45–500 lm in diameter, with a custom-built 3D printer
(ABG 10000, Aerotech Inc., Pittsburgh, PA). They used
cell-laden GelMA and pluronic F127 to print a heteroge-
neous tissue construct with perfusable channels as vascu-
lature. Billiet et al. [36] fabricated hydrogel scaffolds using
a bioplotter (EnvisionTEC, Gladbeck, Germany). The cells
were printed with the scaffold during the process. A scaf-
fold-free system was introduced by Norotte et al. with the
use of a bioprinter, which was manufactured in-house [37].
Multicellular spheroids and cellular cylinders were used as
the building blocks to leave channels for vascular tissue
engineering.
8 Challenges and Prospects
Additive manufacturing has a lot of advantages, but it still
has many challenges that remain to be overcome. Firstly,
the materials used in additive manufacturing are limited to
the materials required for each technique. Few materials
can be used in more than one 3D printing modality.
Incorporating bioactive molecules is another challenge for
additive manufacturing. Bioactive molecules may be sen-
sitive to the printing environment. If the printing processes
involve a solvent or extreme temperature, the folding of
proteins can be affected or the proteins can be denatured.
Methods suitable for bioactive molecule incorporation in
3D implants are limited. Moreover, the biocompatibility of
Fig. 5 Scheme of selective
laser sintering (SLS). Laser
beam scans surface of polymer
powder to sinter into scaffold
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the scaffold following successful but novel fabrication
techniques must be evaluated. Given the limited number of
commercially available materials, it may be challenging to
control degradation, mechanical properties, pore size, and
surface properties. These topics are discussed below.
Control of degradation rate is important for scaffolds
used for tissue regeneration. The degradation rate should be
tuned carefully to synchronize with the regeneration rate of
the neotissue. For instance, poly(a-hydroxy esters) have
been used to create scaffolds for a variety of biomedical
applications [1, 3–5, 7, 38–40]. The degradation rate of
these scaffolds strongly depends on the size and geometry
of the product [38, 39]. The resolution of additive manu-
facturing techniques varies. Overall porosity and pore
interconnectivity also affect the degradation rate [40].
When designing a scaffold, these parameters should be
taken into consideration. Scaffold degradation byproducts
have been studied for most of the materials used in tissue
engineering. Most have good biocompatibility. However,
fast-degrading polymers may cause an inflammatory
response in vivo. Based on the degradation profile and
degradation byproducts, the biocompatibility of materials
should be evaluated as part of the design of the scaffold.
Since the function of a scaffold is to provide a biomi-
metic environment for cell attachment, proliferation and
extracellular matrix secretion, suitable mechanical proper-
ties (e.g., similar to those of natural tissue) are important
for 3D printed scaffolds. This would help cells maintain
their phenotype and could induce the correct matrix
secretion for the neotissue. Huang et al. designed a 3D
environment for the maintenance of the spheroid mor-
phology of MSCs [41]. It should be noted that 3D printing
can sometimes produce scaffolds that are stiffer than those
that can be fabricated using conventional methods.
Although hydrogels are used to fabricate scaffolds, their
mechanical strength may be insufficient. To improve the
strength of hydrogel scaffolds, Wu¨st et al. developed a
special hydrogel composite [42]. They used a two-step
gelation process to make a mixture of alginate and gelatin
hydrogel. Furthermore, hydroxyapatite was added to the
hydrogel at various ratios to provide a mechanically tun-
able construct.
In addition to the mechanical properties, the microen-
vironment varies with tissue. Scaffold pore size require-
ments vary between different tissues and organs. In
conventional scaffold fabrication, the control of the pore
size strongly depends on the process [5, 43–45]. For
instance, scaffolds fabricated from solution freeze-drying
depend on the concentration of the solution and the size of
the ice crystal [43, 44]. The advantage of additive manu-
facturing is the ability to accurately and precisely control
the pore size and geometry [11, 13, 21, 25, 31, 32]. By
adjusting fabrication parameters, various pore sizes may be
easily achieved. However, with pore size control being
possible, it is equally important to determine the optimal
pore size needed for the regenerative process. New studies
on pore size are needed.
Surface properties are another critical parameter for
tissue engineering scaffolds. Surface properties include
topography, hydrophobicity, and roughness. These surface
features are important in cell–scaffold interactions as they
affect how cells respond to the scaffold. For example, the
surface of the scaffold from an SLS process is usually
excessively rough. Although a rougher surface may
increase cell attachment, overly sharp features may damage
cells. The surface of a scaffold fabricated using the FDM
method may be smooth and more suitable for cells. Yen
et al. demonstrated that LFDM scaffolds with a rough
surface (1–2 lm pores) may benefit the proliferation of
attached chondrocytes [15]. The hydrophobicity of the
Table 1 Advantages and disadvantages of various 3D printing techniques
Advantages Disadvantages
Fused deposition modeling Good mechanical properties; solvent not required High temperature; filament required; narrow
process window
Liquid-frozen deposition
manufacturing
Low temperature; can incorporate biomolecules Freeze-drying required
Low-temperature deposition
manufacturing
Stereolithography Smoother surface; high resolution; fast processing High cost; possibly high temperature; toxic
uncured resin
Digital light processing High resolution; fast processing; less shrinkage High cost; toxic uncured resin
Selective laser sintering No supports needed during manufacturing; high
resolution; fast processing
Rough surface finish; high temperature
3D bioplotter Cells and hydrogels can be printed Low mechanical strength; slow processing; low
accuracy
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scaffold may affect cell adhesion to the surface. Hsu et al.
demonstrated that LFDM fabrication of PLGA scaffolds
did not facilitate MSC seeding unless cells were embedded
in alginate [16]. Hsu et al. fabricated chitosan scaffolds
treated with air plasma [14], which reduced hydrophobicity
and thereby enhanced cell seeding. After plasma treatment,
the hydrophobicity of the scaffold was reduced, allowing
cells to be seeded in the scaffolds more easily.
Finally, direct organ fabrication is the ultimate goal of
additive manufacturing in tissue engineering. There is a
possibility of printing a complete organ that could be
directly transplanted into the human body. In this situation,
the patterning of cells and materials in a printed scaffold
would need to be carefully designed.
In conclusion, recent developments in tissue engineering
include various new approaches for creating 3D scaffolds.
Compared to conventional fabrication methods, additive
methods allow scaffolds to be made quickly and accurately.
Moreover, this technology could lead to custom-made
scaffolds for patients. Further developments in additive
manufacturing in tissue engineering will require new bio-
materials, scaffold design optimization, and better knowl-
edge of cell and organ physiology.
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